|Year : 2015 | Volume
| Issue : 1 | Page : 14-24
Technological advances in perioperative monitoring: Current concepts and clinical perspectives
Geetanjali Chilkoti, Rachna Wadhwa, Ashok Kumar Saxena
Department of Anaesthesiology and Critical Care, University College of Medical Sciences and Guru Teg Bahadur Hospital, Shahdara, New Delhi, India
|Date of Web Publication||3-Feb-2015|
Dr. Geetanjali Chilkoti
A 1404, Jaipuria Sunrise Greens, Ahimsa Khand, Indirapuram, Ghaziabad - 121 014, Uttar Pradesh
Source of Support: None, Conflict of Interest: None
Minimal mandatory monitoring in the perioperative period recommended by Association of Anesthetists of Great Britain and Ireland and American Society of Anesthesiologists are universally acknowledged and has become an integral part of the anesthesia practice. The technologies in perioperative monitoring have advanced, and the availability and clinical applications have multiplied exponentially. Newer monitoring techniques include depth of anesthesia monitoring, goal-directed fluid therapy, transesophageal echocardiography, advanced neurological monitoring, improved alarm system and technological advancement in objective pain assessment. Various factors that need to be considered with the use of improved monitoring techniques are their validation data, patient outcome, safety profile, cost-effectiveness, awareness of the possible adverse events, knowledge of technical principle and ability of the convenient routine handling. In this review, we will discuss the new monitoring techniques in anesthesia, their advantages, deficiencies, limitations, their comparison to the conventional methods and their effect on patient outcome, if any.
Keywords: Adverse events, improved outcome, limitations, technological advancement in perioperative monitoring
|How to cite this article:|
Chilkoti G, Wadhwa R, Saxena AK. Technological advances in perioperative monitoring: Current concepts and clinical perspectives. J Anaesthesiol Clin Pharmacol 2015;31:14-24
|How to cite this URL:|
Chilkoti G, Wadhwa R, Saxena AK. Technological advances in perioperative monitoring: Current concepts and clinical perspectives. J Anaesthesiol Clin Pharmacol [serial online] 2015 [cited 2020 Jun 2];31:14-24. Available from: http://www.joacp.org/text.asp?2015/31/1/14/150521
| Introduction|| |
Monitoring in anesthesia is a subject of a lot of research and development. Association of Anesthetists of Great Britain and Ireland (AAGBI) and American Society of Anesthesiologists (ASA) recommended minimal mandatory monitors that is, electrocardiography (ECG), noninvasive blood pressure (NIBP), end-tidal CO 2 , pulse oximetry, and temperature which are universally acknowledged and have now become an indispensible part of the anesthesia practice.  Some patients may require additional invasive monitoring, e.g., vascular or intracranial pressure (ICP), cardiac output (CO) or biochemical variables. Over the last two decades, an increased numbers of medical litigations with subsequent increased attention to patient safety coupled with the advancements in technology have led to enhanced need for improved monitoring. Newer perioperative monitoring techniques include depth of anesthesia (DOA) monitoring; goal-directed fluid therapy (GDFT), transesophageal echocardiography (TOE), neurological monitoring, the advancement in the alarm system and technological advancement in perioperative pain assessment. Whether an overreliance on new technologies in perioperative monitoring has improved the patient outcome continues to be a topic of debate. 
An extensive literature search was performed through Medline, PubMed, Google Scholar and textbooks using the key words "DOA monitoring," "GDFT," "improved perioperative monitoring," "neurological monitoring," "neuromuscular monitoring (NMM)," "perioperative mortality," "temperature monitoring," "alarms and cognition" and "objective pain assessment." Moreover, the "adverse events or limitations" of each monitoring technique were searched separately. In this narrative review, we have discussed the studies and evidences related to the new monitoring techniques in anesthesia, their advantages, their limitations and their comparison to the conventional methods and their effect on patient outcome, if any.
| Anesthesia related morbidity and mortality|| |
The mortality directly attributed to anesthesia has reduced over the last 25 years from 1 death in 2680 anesthetics in 1950s to 1 death in 10,000 anesthetics in 1980s. , In 1990s, the anesthesia induced cardiac arrest rate and death were observed to be 15/20,080 and 1 in 2500-3000 respectively.  The perioperative risk of death after general anesthesia (GA) may range from 1% to as high as 33% in high risk individuals. , The recent data on anesthesia mortality from the triennial reports of anesthetic mortality review committee, Australia have shown that anesthesia has become safer over time and that the risk of death directly attributable to it in healthy patients undergoing minor or moderate surgical procedures is nearly 1 in 200,000.  Various studies of mortality associated with anesthesia have shown that adverse incidents are frequently attributed to human errors. , Anesthesiologist's vigilance and experience about to the continuous display of data on the monitor is of paramount importance. In fact, "vigilance" is the motto of the ASA. As far as the anesthesiologist's experience is concerned, a recent retrospective analysis have evaluated the effect of experience in providing deep sedation for endoscopic retrograde cholangiopancreatography on safety and cost, and it was observed that anesthesiologist on a regular basis performed better than those on ad-hoc basis.  Monitoring can significantly reduce the risk of accidents by giving warning of the patients changing condition or by detecting the consequences of errors. Medications-related cardio-circulatory events and airway complications are few of the major causes of anesthesia related morbidity and mortality.  However, it is difficult to sort out the mortality due to surgery and patient disease from that due to the technical errors. Many anesthesiologists cite improved monitoring as the reason for the reduction in anesthetic-related mortality over the years. Better monitoring could have been only one of the reasons for the downward trend in anesthetic mortality. There are many other factors which have influenced the anesthesia related mortality over the years like improved training, availability of safer anesthetic agents and change in population anesthetized as a result of changes in surgical practice. 
| Monitoring standards in anesthesia|| |
The minimum mandatory monitoring by ASA and the AAGBI includes ECG, NIBP, pulse oximetry, and capnography while a nerve stimulator and temperature monitor should be immediately available.  The utility of ASA recommended minimal mandatory monitoring or basic monitoring is universally acknowledged. In our country, the Indian Society of Anaesthesiologists (ISA) recommended mandatory peri-operative monitors are considered as national standards.  Additional monitoring like continuous invasive arterial blood pressure, central venous pressure (CVP) monitoring, TOE, NMM etc., may be necessary as deemed appropriate by the anesthesiologists. The first landmark advancement in monitoring technology occurred in 1980's with the advent of pulse oximetry in clinical practice. A significant Cochrane review highlighted data from four trials including 21,000 patients and confirmed that pulse oximetry could detect hypoxaemia and related events, but there was little evidence that it affects the perioperative mortality and morbidity.  However the role of basic monitoring like pulse oximetry is proven despite lack of robust randomized controlled trials (RCTs) comparing pulse oximetry, a basic monitoring with no monitoring.
Monitoring in anesthesia practice usually refers to the display of both the patient's physiological variables and the variables assessing the anesthesia machine function. Continuous monitoring is believed to cause an early recognition and thus the correction of any physiological abnormalities. But continuous electronic patient monitoring may not always be beneficial. Rapid recognition of the altered condition is of help only if there is a treatment for the underlying cause. Even if the treatment is available, early detection is of help only if treatment is more effective when delivered quickly.  More information may bring more ways of misinterpretation.
If we really wish to evaluate that the reduction in perioperative morbidity and mortality is attributable to improve monitoring, we have two ways to rely upon. First, we can find studies looking at the trends of anesthetic mishaps over time and correlate this with the trends in the monitoring. But it is difficult to differentiate the mortality due to deficient monitoring from that due to various other factors. Second, the best method would be to compare the conventional monitoring with or without a new device in a clinical trial.  Hence in this review we shall discuss the studies related to new monitoring techniques in anesthesia, their comparison to the conventional gold standard technique and effect on patient outcome, if any.
The continuous monitoring of ASA recommended minimal monitors are a must in the intraoperative period.  Temperature monitoring is an important aspect of perioperative monitoring both under general or regional anesthesia. Various RCTs have shown that the mild hypothermia considerably increases the risk of surgical wound infection,  morbid myocardial outcomes,  blood loss and transfusion requirement  and prolongs recovery  in a wide variety of surgical procedures. Recently updated "American Heart Association-American College of Cardiology 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery" includes a level 1 recommendation for maintenance of perioperative normothermia in patients undergoing surgical or therapeutic procedures under general or regional anesthesia exceeding 60 min by use of active warming measures or by achievement of target temperature of 26°C in the operating room and the postanesthesia care unit.  Despite the strong level of recommendation and easy to implement measures of temperature monitoring, there lies a substantial gap in the thermal management practice. Thus, perioperative thermal management has now emerged as an ideal area for performance measurement and improvement as with minimal effort and cost it can markedly improve the surgical and patient outcome.
The routine use of NMM has been controversial despite the presence of adequate scientific evidence in its favor. Residual neuromuscular blockade is a common complication following use of neuromuscular blockers and is a major cause of morbidity and mortality in the immediate postoperative period.  An Australian survey has shown that the incidence of residual neuromuscular blockade has increased from 21% in 1986-31% in 2010.  NMM improves the quality of intubation, is helpful in maintaining adequate neuromuscular blockade intraoperatively and for diagnosing residual paralysis in the immediate postoperative period.  Acceleromyography (AMG) is the most versatile method in the clinical setting because of its applicability at various muscles and ease of use as it lacks technical difficulties of the traditional methods.  Despite the increased incidence of residual paralysis, advanced understanding of the physiology of neuromuscular transmission by anesthesiologist, and the scientific evidence in favor of NMM, it continues to be an optional monitor in the perioperative period.  In the year 2000, Baillard et al., showed that intraoperative NMM using AMG as an objective method, in conjunction with an effort to educate the clinicians, led to a reduction of residual paralysis from 62% to very low levels.  This landmark finding contributed to the provision of routine use of NMM in all the operating rooms. Later, a survey in United kingdom among 718 anesthetists have shown that only10% used NMM routinely, and 28% used it occasionally and 68% had never used it.  Even according to the "ASA task force on the postanesthetic care" the assessment of neuromuscular function includes NMM only occasionally.  The probable causes for the occasional use of NMM are that the clinicians are not convinced of the benefits provided by the monitors, lacks adequate training and knowledge of the inherent technical factors. , So, the controversy whether NMM is used routinely continues despite the presence of adequate scientific evidence.
The new high standard anesthesia work stations, e.g. Drager provides a new level of efficient performance, safety and allows the anesthesiologist to focus on the primary task - the patient. These advanced anesthesia work stations have distinctive features like auto self-check, open architecture, and incorporate flexible monitoring which include continuous measurement of exhaled CO 2 , oxygen, anesthetic-gas monitoring, pulmonary functions and various ventilation parameters. Continuous monitoring of these parameters may not be required in all and should be considered depending upon its availability, and patient population anaesthetized. Monitoring of these parameters has been an integral part of the newer anesthesia workstations, but no trials have been attempted for comparing the patient outcome with or without their use.
Newer monitors also incorporate software like anesthesia information system which has completely replaced the paper recording system.  Electronic anesthesia record is more contemporaneous, complete, and legible than the handwritten records. A feared problem with its use may be increased malpractice exposure as some evanescent perioperative physiological changes and the artifactual data from the monitors may be misinterpreted in the event of unfavorable patient outcome. , Hence, although introduced almost 25 years ago, its use in clinical practice is still limited, due to which there is no evidence of improved patient outcome with its use.
Intracranial pressure monitoring continues to be an essential monitor in neurosurgery. Till 2006, only an observational study by Steiner and Andrews had suggested that ICP oriented therapy increases the treatment intensity without any improvement in outcome.  In 2012, Meyfroidt highlighted the need of RCTs in this regard  and finally recently, a multi-centric RCT involving 324 patients with severe traumatic brain injury, have shown that ICP monitoring does not show superior results when compared to the care based on imaging and clinical examination.  Moreover, there is still the controversy concerning the critical thresholds for ICP in children.  Moreover, the gold standard for assessing ICP is an intraventricular catheter, but its use in clinical practice is limited as the risk of infections is in the range of 6-11%. The accuracy of alternative devices that is, intraparenchymal, subarachnoid, subdural and epidural devices have been found to be lower than the intraventricular catheter.  High ICP and cerebral hypoxia shows a strong correlation with poor outcome. Thus cerebral perfusion pressure (CPP) should be optimized. CPP when used as a target for therapy, there is further controversy as to which threshold should be used. , CPP would also depend upon the monitored levels of cerebral oxygenation and should be optimized individually.
Various monitors of cerebral oxygenation include imaging methods like positron emission tomography (PET), magnetic resonance spectroscopy (MRS) and nonimaging methods like jugular venous oximetry (SjO 2 ), near-infrared spectroscopy, intracerebral microdialysis and brain tissue oxygen tension (PbO 2 ). PET is regarded as the gold standard despite its many limitations such as radiation exposure, limited availability, snapshot nature of the technique, and poor spatial resolution. Similarly, the routine use of MRS is limited due to postprocessing and nonuniform availability. 
Jugular venous oximetry (SjO 2 ) is considered to be an integral part of the neurological monitoring as it gives information on the adequacy of cerebral blood flow in relation to the metabolic demand of the brain.  SjO 2 monitoring is highly sensitive in the presence of global hypoxemia or ischemia, but the shortcoming is the inability to detect focal ischemia. Despite the many limitations of the method and the lack of grade 1 evidence, interest is still being focused on SjO 2 monitoring.  Brain tissue oxygen partial pressure (PbO 2 ) has emerged as a reliable monitor of cerebral oxygenation more so during the course of interventions such as CPP manipulations and hyperventilation. The invasiveness of the PbO 2 monitor has limited its usefulness, but combining parameters such as ICP and PbO 2 into a single probe have now reduced the number of probes inserted.
Transcranial Doppler ultrasonography was introduced in 1982 as a noninvasive technique for monitoring blood flow velocity, CPP, vascular reactivity, and the emboli in the basal cerebral arteries. It is also being used as an intra-operative monitor in anesthesia for the management of patients undergoing neuro-vascular surgery and carotid end-arterectomy as it detects microemboli and postsurgical blood flow velocity. However, its reliability as a perioperative monitor is still under investigation. 
Cerebral microdialysis has been in use since 1992 and provided useful information for the management of critical neurological patients as it analyzes a broad range of metabolites and mediators of brain damage in anaesthetized patients.  This technique till now is reserved only for research purpose as it is expensive, requires technical resources, results are not immediate or continuous and moreover, the interpretation of the resulting information into clinical practice is not easy. 
Depth of anesthesia monitoring
The second-step change in monitoring occurred recently in the last decade when the DOA monitoring using the processed electroencephalography (EEG) signal became so simple to be used as routine monitor. The first DOA monitor was bispectral index (BIS) monitor and was introduced in 1992 and after few years, various others were introduced like Narcotrend index, auditory evoked potential (AEP) monitor, patient state analyzer (PSA), entropy, cerebral state monitor (CSM) etc.
All DOA monitor calculates an index or a value derived from the EEG, which can measure the hypnotic component of anesthesia. The use of DOA monitor can help in detecting awareness and thus titrate anesthetic agents and keeps a balance between anesthetic requirement and anesthetic drug administration. The reported incidence of intraoperative awareness varies from 0.2% to 2%.  The inflated incidence, as reported by various trials may also be reflected by various factors that is, underlying physiologic variation, alternative anesthetic technique, differential reporting and substantial inflation due to false memories.  On the contrary, Sebel et al. in a multicentric trial have reported an incidence of awareness to be as low as 0.13-0.18%.  Moreover, a recent national survey by Pandit et al., reported an intra the-operative awareness of 1: 15,000 under GA which approximately translates to 180 cases in UK annually, the audit also prompted reconsideration of detection and incidence of awareness.  The result of this survey was found to be dramatically different from 1 to 2: 1000 established in the previous studies. , But the real incidence of awareness during anesthesia remains unknown as there has been a lot of variation in the reported incidence of awareness worldwide.
The main limitations of DOA monitoring are that various physiological factors influence EEG; moreover, it may have diverse outcome measures. Physiological factors such as age, race, gender, low body temperature, acid base imbalances, low blood glucose, or cerebral ischemia have significant influence on EEG. , The outcome measures with DOA monitoring are diverse that is, probability of awareness, consumption of anesthetic agents, time to extubation or discharge from the recovery room, and other sequelae resulting from the awareness during surgeries like postoperative cognitive dysfunction and mortality.
There are many practical limitations with DOA monitoring. Firstly, not all are validated to the same extent except BIS. Secondly, the clinical ranges of various DOA monitors are not identical across the devices. Thirdly, now there is enough evidence that awareness can still occur even with DOA monitoring. A large study in Australia popularly known as the "B-aware study" has clearly demonstrated that the use of BIS can reduce the awareness but does not prevent it with number needed to treat 138.  Recently, Avidan et al., compared BIS with end tidal anesthetic gas monitoring in 6000 patients and concluded that no difference in awareness was found with the use of BIS.  Liu in a meta-analysis of RCTs s of 1380 ambulatory patients reported that BIS monitoring reduced the anesthesia requirement by 19% and the risk of postoperative nausea and vomiting by 6%, but reduced the time spent in postanesthesia care unit by only 4 min.  Fourthly, the DOA monitoring when used intraoperatively, although reduces the drug consumption and accelerate recovery but it does not translate into early discharge or improved outcome.  Moreover, the cost savings made by DOA monitoring were entirely cancelled out by the cost of disposables required for the monitoring.  In addition, titration of hypnotic agents using DOA monitors is mainly the manufacturer recommendation and good substantiation of this recommendation are lacking.  So, the use of DOA monitor in all patients remains an economic decision, and cost benefits analysis needs to be done. There are various other DOA monitoring techniques, e.g., AEP monitor, PSA-4000 monitors, CSM and entropy [Table 1]. All of them have been studied to a very limited extent due to various limitations and nonuniform availability.
Narcotrend monitor has less interference with electromyography (EMG) than BIS monitor.  The Narcotrend guided sedation demonstrates lower hemodynamic changes and fewer complications when compared to the clinical assessment guided sedation.  AEP monitor was introduced in 2000 and were more sensitive in monitoring DOA and in predicting recovery than BIS.  AEP features an AEP and the EEG-derived hybrid index of patient's hypnotic state. The monitor uses exogenous input (ARX) to measure the AEP. This monitor calculates the AEP-ARX-Index (AAI index), which is a dimensionless number and is `displayed on two scales, 0-100, and from 0 to 60. The drawback is that the EMG artifacts can influence the values as the EMG also propagates in the same frequency band. 
PSA-4000 monitor, calculates the value of the index from four EEG channels which are also a dimensionless number from 100 (awake) -0 (isoelectric).  The ability of CSM to monitor DOA is comparable to other available EEG-based devices. The drawback is its slow response to change in sedation.  Hoymork et al., monitored hypnotic effects in 87% of nonparalyzed patients using CSM and in 13% of patients the values indicated an awake state despite clinical sleep. However, the study was done with the initial version of CSM. 
Entropy was introduced in 2003 by the Datex-Ohmeda. This monitor displays two index values, e.g., state entropy (SE) and response entropy (RE) based on EEG and EMG respectively. SE is resistant to facial muscles contraction response and hence SE is a measure of hypnotic effect of AA. No definitive manufacturer recommendation or technical specification is available and result interpretation is at the discretion of the anesthetists and may have inter-individual variation. None of these new DOA monitors has been compared to the BIS, which is a clinically established DOA monitor in terms of its ability to detect awareness.
Another parameter with DOA monitoring is response time to change in the level of sedation or anesthesia as the processing, classification and averaging of EEG derived indices needs time. The response time has not found to be constant and varied from 30 to 100 s for the transition between sedated and awake state for BIS, Narcotrend and CSM. 
As we have discussed, awareness can still occur in patients receiving DOA monitoring, if the cause is failure of the monitoring algorithm or artifact detection, specific patient condition, or human error requires further study.  Until date, no monitoring system can reliably measure the DOA for all patients and all anesthetic agents.  Moreover, all DOA monitor can measure the hypnotic component and not the patient's stress level in response to nociceptive stimulus during GA.  Monitoring of the stress response is equally important as prolonged stress response delays recovery and increases the perioperative morbidity.  Various other indices like surgical stress index (SSI), the response index of nociception and the noxious stimulation response index have been found to be superior to BIS and AAI index.  But has been very little used in clinical practice. The ASA Task force states that brain function monitoring is not routinely indicated for patients undergoing GA, either to decrease the frequency of intra-operative awareness or to monitor the DOA.  To conclude, all DOA monitor add another parameter and in no way relieves the anesthesiologist of the need to use clinical judgment and to be vigilant. The development and the future perspective of DOA monitor would definitely depend upon the universal applicability of a single validation protocol.
Goal directed fluid therapy and relevant monitoring
The "third-step change" in anesthesia monitoring is the development of simple relatively noninvasive device to measure CO and stroke volume in anaesthetized patients. The GDFT was introduced by Emanuel. Rivers in 2001 and was used in critical care medicine and then in the perioperative period for aggressive management of hemodynamics in high-risk patients undergoing cardiac surgery.  Pulmonary artery (PA) catheter was the core technology in the earlier GDFT studies.
The thermodilution technique of determining CO using a PA catheter has been the gold standard technique. In last few years, it has been proven that PA catheterization has no effect on mortality or on hospital stay in high risk surgical patients despite high incidence of adverse events.  Intermittent methods such as indicator dilution are widely used, but continuous CO monitoring is required clinically. The devices studied extensively in RCTs s are the esophageal Doppler cardiac output monitor (ODCM), pulse contour cardiac output (PCCO) monitor and TOE. All of these monitoring devices are used as part of a feedback process, to assess the fluid status and replace circulating volume to a target stroke volume or CO. In last one decade, numerous studies were performed with ODCO guided fluid strategies. A systematic review conducted by evidence based practice center in USA tried to conclude that therapeutic management based on ODCO monitor during surgery leads to improved patient outcome when compared to PA based measurement of CO via thermodilution or CVP measurements.  This systematic review comprised of total 7 publications involving 583 patients. None of the prospective RCT compared ODCO monitor to thermodilution method that is the gold standard. Moreover, most of the studies used ODCO monitor as a device to be used in complementary to CVP method.  Various studies in the past have demonstrated a positive effect of ODCO guided fluid therapy on the length of hospital stay, morbidity and mortality. , On the contrary, recently Challand et al., and Brandstrup et al., conferred no additional benefit of ODCO for GDFT over the standard fluid therapy in colorectal surgery in terms of hospital stay and complication rates. , Cochrane review on the use of ODCO monitor for perioperative fluid volume optimization following proximal femoral fracture has been found to be inconclusive in terms of its effect on patient outcome. 
ODCO monitoring, although considered a gold standard for monitoring GDFT perioperatively but it may have limitations. It has been observed that only 37% of patients who have decreased SV perioperatively respond to the fluid bolus  and the absolute measurement may also vary by 40%. 
NICE  and the UK GIFFTASUP  guidelines support the use of GDT in high risk surgical patients; however, its use in high risk surgical patients as a routine is highly debatable. 
Cardiac output by PCCO monitor calculates CO from the arterial pressure waveform of a peripheral artery using autocorrelation by nonlinear transformation of the input analogue arterial pressure. The first publication on PCCO monitor was in 1904 and preceded Kortokoff's auscultation paper by 1-year.  The advantages are that it is less invasive and can detect beat-by-beat CO. However, several calibrations are required intraoperatively to measure the CO. And there can also be a miscalculation of CO by PCCO monitor as the arterial pressure waveform changes with the change in arterial compliance according to sympathetic activity, intravascular blood volume, and patient's position, etc.  In view of its limitations, none of the studies has compared PCCO with the gold standard techniques like PA catheter or ODCM.
In late 1980s, TOE was introduced in cardiac anaesthesia and was considered as a noninvasive tool for monitoring the left ventricle function. Since then its use has expanded and now has become a standard intraoperative diagnostic tool for the management of patients undergoing cardiac surgery  as well as other major surgical procedures like lung transplantation, liver transplantation, and aortocardiac surgical patients where it often provides new and important information about pathology and may guide both surgical and anesthetic therapy. , TOE is also useful in guiding therapy in hemodynamically unstable patients in the operating room, and in the Intensive Care Unit (ICU), as simple TOE view can distinguish the hypotensive patients from the one with primary pump failure. But, no evidence supporting this practice is available. 
TOE is relatively safe and noninvasive. The potential injury related to TOE include oral injury, oropharyngeal, laryngeal, esophageal, gastric injury and gastric bleeding, arrhythmia and hemodynamic effects. , The use of TOE in the intraoperative period poses a higher risk profile in comparison to its use in a nonoperative setting as it requires probe placement and manipulation in intubated patients.  Overall TOE related morbidity when used intraoperatively have been found to be similar to nonoperative patients and ranges from 0.2% to 1.2%.  Lennon et al., surveyed patients for late complications and suggested that the rate of major gastrointestinal (GI) injuries (e.g., gastric lacerations, hemorrhage, or perforation) could be as high as 1.2% and may present after 24 h.  They concluded that the underestimation of the overall risk of TOE in the past could have been a reason for possible delay in clinical manifestation of TOE-related GI injury.  The other problems with TOE include TOE related endotracheal tube malposition and recurrent laryngeal nerve injury in neurosurgical patients.  The familiarization with potential complications of TOE is needed to allow risk benefits analysis on an individual basis.
The improved patient outcome following use of TOE in cardiac patients is an established fact; however, no data suggesting the risk reduction in noncardiac patients is available [Table 2].
American Society of Anesthesiologists task force and the society of cardiovascular anesthesiologists task force on TOE recommends a basic training in perioperative TOE in general anesthetic practice.  However, when not used routinely, one may face difficulty in skill retention. It also carries the risks associated with the procedure itself and does require the need of providing training and experience for the practitioner. TOE has resulted in a significant change in the status of anesthesiologists. As now not only can they diagnose any ischemic episode periopertively but can also assess the effectiveness and guide the surgical intervention along with the surgeons. The rapid proliferation of TOE may be technology driven but should be used as an accessory tool to have a more comprehensive understanding of the patient's cardiovascular physiology in relation to the disease and surgical intervention. The skill development and retention are deemed essential to enhance the utility of this monitoring technique [Table 3].
| Alarms and cognition|| |
Alarms are the integral part of the anesthesia monitor and being used in many clinical applications. Increased attention to safety and numbers of medical litigation following an adverse event in anesthesia practice has led to the widespread use of alarm system. The alarms are observed to be frequently too numerous, confusing, too loud, badly designed resulting in hindrance rather than improved performance.  One of the developments in alarm technology is an intelligent alarm system. The key advantage is the low false alarm rates, as it monitors and integrates the output of several parameters at once, or in principle, by a neural net.  The various reasons for alarm failure could be a mismatch between technology and the fundamental psychological principles of perception, attention, learning, and memory. Thus, the cognitive capacity and processing mechanism of the user must be considered while designing and implementation of the alarms in clinical practice and is a potential focus for future research. "ASA recommendations for standards for monitoring under anesthesia" states that alarm limits for all equipments must be set before use and all audible alarms must be enabled during anesthesia. However, this again is a potential area for performance measurement and improvement.
Technological advancement in perioperative pain assessment
Inadequate postoperative pain management may have many undesirable effects like increased hospital stay, impaired quality of life, development of chronic pain and increased morbidity and mortality. Postoperative pain management is one of the most challenging factors for determining patient outcome following surgery. Thus, regular and comprehensive pain assessment in the perioperative period would help in improving the postoperative acute pain management. There are various scales and questionnaires for subjective pain assessment tools and are categorized into uni-dimensional (numerical rating scale, visual analogue scale, faces pain scale) and multidimensional (neuropathic pain assessment NPS, Mc Gill's pain questionnaire. The technological advancement in the objective assessment of pain has occurred recently with the introduction of pain assessment monitors like algesimetry and surgical pleth index (SPI). Algesimeter is a device used to detect the sensitivity of the skin to a painful stimulus and is faster and more sensitive and specific when compared to other objective pain assessment methods. SPI is a parameter based on plethysmographic pulse amplitude and pulse interval and reflects the patients' hemodynamic response to surgical stimuli and analgesic medication during GA. The sensitivity and specificity of algesimetry in the perioperative period is found to be around 90% when compared with clinical stress variables.  Whereas, SPI does not show superior results when compared with other hemodynamic variables to assess nociception and anti-nociception balance during GA.  Ledowski et al., had observed that skin conductance algesimetry is an efficient perioperative monitor to predict postoperative pain and to assess its intensity. , Later in 2009, Ledowski et al., also showed the increased specificity and sensitivity of algesimetry in predicting postoperative pain when compared to the SSI.  However, in the same year, Storm et al.,  highlighted the fact that the pain detection sensitivity of this study was markedly different from his own previous studies. ,, The limited research and marked variation in the results of the various studies related to algesimetry poses question on its effectivity as a perioperative monitor. Similarly, with SPI, most of the preliminary studies were done in patients undergoing GA with propofol and remifentanyl. These trials showed that SPI-guided remifentanil administration reduces remifentanil and propofol consumption and shortens recovery times in outpatient anesthesia.  So, it was concluded that SPI may be used as a bedside tool to measure pain during surgery. But so far, the related studies are limited, and all are performed under GA and till now, no study has investigated SPI or algesimetry under regional anesthesia. All current pain assessment monitors require further development and testing for accuracy and reliability.
| Future perspectives and conclusion|| |
The monitoring devices of the future will have an additional advantage that it would enables automated correction of physiological abnormalities simultaneously, e.g., pharmacokinetic-based anesthesia infusion pumps with DOA monitoring or newer ventilators that can automatically adjust the ventilator settings by monitoring lung mechanics. These new monitoring techniques can potentially reduce the element of human error.
To conclude, new and improved monitoring techniques have undoubtedly led to dramatic changes in anesthesia practice. Various factors that need to be considered with the use of improved monitoring techniques are the validation data, patient outcome, safety profile, cost effectiveness, awareness of the possible adverse events, knowledge of technical principle and ability of the convenient routine handling. So far, there is a lack of substantial evidence if these new improved monitoring techniques have improved patient outcome. How often these improved monitors are used for a particular indication also varies from institution to institution. Most of the new monitoring techniques have been evaluated to a limited degree. More over the main barrier to research evaluating the patient outcome with these new monitoring techniques include its non-uniform availability. In developing nation like ours, we must ensure the implementation of minimal mandatory monitoring standards as recommended by ASA and AAGBI. We must reinforce that vigilance is the key and optimal vigilance requires an understanding of the technology of sophisticated monitoring equipments - including the cost benefit consideration. We being anesthesiologists, must be aware of the recent developments in monitoring, must use it where it is indicated and should be in a position to direct them by using our clinical acumen. We should always remember that we must monitor the monitors.
| References|| |
AAGBI. Recommendations for Standards of Monitoring During Anaesthesia and Recovery. London: The Association of Anaesthetists of Great Britain and Ireland; Revised 2007.
Tinker JH, Dull DL, Caplan RA, Ward RJ, Cheney FW. Role of monitoring devices in prevention of anesthetic mishaps: A closed claims analysis. Anesthesiology 1989;71:541-6.
Pedersen T. Mortality associated with anesthesia. Baillieres Clin Anaesthesiol 1996;10:237-50.
Gibbs NM (ed). Safety of anesthaesia in Australia 2003-2005. Melbourne: Australian and New Zealand College of Anaesthetists, 2009.
Pedersen T. Complications and death following anaesthesia. A prospective study with special reference to the influence of patient-, anaesthesia-, and surgery-related risk factors. Dan Med Bull 1994; 41:319-31.
Merry AF, Webster CS. Has anesthesia care become safer and is anesthesia-related mortality decreasing? F1000 Med Rep 2009; 1:69.
Webb RK, Currie M, Morgan CA, Williamson JA, Mackay P, Russell WJ, et al.
The Australian Incident Monitoring Study: An analysis of 2000 incident reports. Anaesth Intensive Care 1993;21:520-8.
Goudra BG, Singh PM, Sinha AC. Anesthesia for ERCP: Impact of Anesthesiologist′s Experience on Outcome and Cost. Anesthesiol Res Pract 2013;2013:570518.
Braz LG, Braz DG, Cruz DS, Fernandes LA, Módolo NS, Braz JR. Mortality in anesthesia: A systematic review. Clinics (Sao Paulo) 2009;64:999-1006.
Kotur PF. Monitoring and the anaesthesiologists. Indian J Anaesth 2002; 46:244-5.
Pedersen T, Møller AM, Hovhannisyan K. Pulse oximetry for perioperative monitoring. Cochrane Database Syst Rev 2009: CD002013.
Young D, Griffiths J. Clinical trials of monitoring in anaesthesia, critical care and acute ward care: A review. Br J Anaesth 2006; 97:39-45.
Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, Fleischmann KE. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. J Am Coll Cardiol 2007;50:1707-32.
Kurz A, Sessler DI, Lenhardt R. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group. N Engl J Med 1996;334:1209-15.
Frank SM, Fleisher LA, Breslow MJ, Higgins MS, Olson KF, Kelly S, et al.
Perioperative maintenance of normothermia reduces the incidence of morbid cardiac events. A randomized clinical trial. JAMA 1997;277:1127-34.
Rajagopalan S, Mascha E, Na J, Sessler DI. The effects of mild perioperative hypothermia on blood loss and transfusion requirement. Anesthesiology 2008;108:71-7.
Lenhardt R, Marker E, Goll V, Tschernich H, Kurz A, Sessler DI, et al.
Mild intraoperative hypothermia prolongs postanesthetic recovery. Anesthesiology 1997;87:1318-23.
Association of Surgical Technologists. (2011). Core curriculum for surgical technology (6 th
ed.). Littleton, CO: Author.
Murphy GS, Brull SJ. Residual neuromuscular block: Lessons unlearned. Part I: Definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth Analg 2010;111:120-8.
Yip PC, Hannam JA, Cameron AJ, Campbell D. Incidence of residual neuromuscular blockade in a post-anaesthetic care unit. Anaesth Intensive Care 2010; 38: 91-5.
Mencke T, Echternach M, Plinkert PK, Johann U, Afan N, Rensing H, et al.
Does the timing of tracheal intubation based on neuromuscular monitoring decrease laryngeal injury? A randomized, prospective, controlled trial. Anesth Analg 2006; 102:306-12.
Fuchs-Buder T, Schreiber JU, Meistelman C. Monitoring neuromuscular block: An update. Anaesthesia 2009; 64 Suppl 1:82-9.
American Society of Anesthesiologists Task Force on Postanesthetic Care. Practice guidelines for postanesthetic care: A report by the American Society of Anesthesiologists Task Force on Postanesthetic Care. Anesthesiology 2002;96:742-52.
Baillard C, Gehan G, Reboul-Marty J, Larmignat P, Samama CM, Cupa M. Residual curarization in the recovery room after vecuronium. Br J Anaesth 2000;84:394-5.
Baillard C, Clec′h C, Catineau J, Salhi F, Gehan G, Cupa M, et al.
Postoperative residual neuromuscular block: A survey of management. Br J Anaesth 2005;95:622-6.
Balust J, Macario A. Can anesthesia information management systems improve quality in the surgical suite? Curr Opin Anaesthesiol 2009;22:215-22.
Kadry B, Feaster WW, Macario A, Ehrenfeld JM. Anesthesia information management systems: Past, present, and future of anesthesia records. Mt Sinai J Med 2012;79:154-65.
Epstein RH, Dexter F. Mediated interruptions of anaesthesia providers using predictions of workload from anaesthesia information management system data. Anaesth Intensive Care 2012;40:803-12.
Steiner LA, Andrews PJ. Monitoring the injured brain: ICP and CBF. Br J Anaesth 2006;97:26-38.
Meyfroidt G. Intracranial pressure monitoring in severe traumatic brain injury: The time for a randomized controlled trial is now. Crit Care Med 2012;40:1993-4.
Chesnut RM, Temkin N, Carney N, Dikmen S, Rondina C, Videtta W, et al.
A trial of intracranial-pressure monitoring in traumatic brain injury. N Engl J Med 2012 27;367:2471-81.
Bennett TD, Riva-Cambrin J, Keenan HT, Korgenski EK, Bralton SL. Variations in ICP monitoring and outcome in paediatric traumatic brain injury; ICP monitoring and outcome. Arch Pediatr Adoles Med 2012;166:641-7.
Nortje J, Gupta AK. The role of tissue oxygen monitoring in patients with acute brain injury. Br J Anaesth 2006;97:95-106.
Nakamura S. Monitoring of jugular venous oxygen saturation. Nihon Rinsho 2011;69:704-7.
Kiening KL, Unterberg AW, Bardt TF, Schneider GH, Lanksch WR. Monitoring of cerebral oxygenation in patients with severe head injuries: Brain tissue PO2 versus jugular vein oxygen saturation. J Neurosurg 1996;85:751-7.
Moppett IK, Mahajan RP. Transcranial Doppler ultrasonography in anaesthesia and intensive care. Br J Anaesth 2004;93:710-24.
Tisdall MM, Smith M. Cerebral microdialysis: Research technique or clinical tool. Br J Anaesth 2006;97:18-25.
Revuelto-Rey J, Egea-Guerrero JJ, Muñoz-Sánchez MA, Murillo-Cabezas F. Cerebral microdialysis in the current clinical setting. Med Intensiva 2012;36:213-9.
Avidan MS, Mashour GA. The incidence of intraoperative awareness in the UK: Under the rate or under the radar? Br J Anaesth 2013;110:494-7.
Bruhn J, Myles PS, Sneyd R, Struys MM. Depth of anaesthesia monitoring: What′s available, what′s validated and what′s next? Br J Anaesth 2006;97:85-94.
Sebel PS, Bowdle TA, Ghoneim MM, Rampil IJ, Padilla RE, Gan TJ, et al.
The incidence of awareness during anesthesia: A multicenter United States study. Anesth Analg 2004;99:833-9.
Pandit JJ, Cook TM, Jonker WR, O′Sullivan E. A national survey of anaesthetists (NAP5 baseline) to estimate an annual incidence of accidental awareness during general anaesthesia in the UK. Br J Anaesth 2013;110:501-9.
Liu WH, Thorp TA, Graham SG, Aitkenhead AR. Incidence of awareness with recall during general anaesthesia. Anaesthesia 1991;46:435-7.
Schultz A, Grouven U, Zander I, Beger FA, Siedenberg M, Schultz B. Age-related effects in the EEG during propofol anaesthesia. Acta Anaesthesiol Scand 2004;48:27-34.
Kodaka M, Johansen JW, Sebel PS. The influence of gender on loss of consciousness with sevoflurane or propofol. Anesth Analg 2005;101:377-81.
Myles PS, Leslie K, McNeil J, Forbes A, Chan MT. Bispectral index monitoring to prevent awareness during anaesthesia: The B-Aware randomised controlled trial. Lancet 2004;363:1757-63.
Avidan MS, Zhang L, Burnside BA, Finkel KJ, Searleman AC, Selvidge JA, et al
. Anesthesia awareness and the bispectral index. N Engl J Med 2008;358:1097-108.
Liu SS. Effects of Bispectral Index monitoring on ambulatory anesthesia: A meta-analysis of randomized controlled trials and a cost analysis. Anesthesiology 2004;101:311-5.
White PF, Ma H, Tang J, Wender RH, Sloninsky A, Kariger R. Does the use of electroencephalographic bispectral index or auditory evoked potential index monitoring facilitate recovery after desflurane anesthesia in the ambulatory setting? Anesthesiology 2004;100:811-7.
Yli-Hankala A, Vakkuri A, Annila P, Korttila K. EEG bispectral index monitoring in sevoflurane or propofol anaesthesia: Analysis of direct costs and immediate recovery. Acta Anaesthesiol Scand 1999;43:545-9.
Gelb AW, Leslie K, Stanski DR, Shafer SL. Monitoring the Depth of Anaesthesia. In Miller RD, Eriksson LI, Fleisher LA, Wiener Kronish JP, Young WL, editors.. Miller′s Anaesthesia. 7 th
ed. Philadelphia, PA: Churchill Livingston Publishers 2010; pp 1253.
Amornyotin S, Chalayonnawin W, Kongphlay S. Deep sedation for endoscopic retrograde cholangiopancreatography: A comparison between clinical assessment and Narcotrend( TM
) monitoring. Med Devices (Auckl) 2011;4:43-9.
Nishiyama T, Hanaoka K. The A-line ARX index may be a more sensitive detector of arousal than the bispectral index during propofol-fentanyl-nitrous oxide anesthesia: A preliminary investigation. Can J Anaesth 2004;51:539-44.
Horn B, Pilge S, Kochs EF, Stockmanns G, Hock A, Schneider G. A combination of electroencephalogram and auditory evoked potentials separates different levels of anesthesia in volunteers. Anesth Analg 2009;108:1512-21.
Drover DR, Lemmens HJ, Pierce ET, Plourde G, Loyd G, Ornstein E, et al.
Patient State Index: Titration of delivery and recovery from propofol, alfentanil, and nitrous oxide anesthesia. Anesthesiology 2002;97:82-9.
Pilge S, Blum J, Kochs EF, Schöniger SA, Kreuzer M, Schneider G. Does the cerebral state index separate consciousness from unconsciousness? Anesth Analg 2011;113:1403-10.
Hoymork SC, Hval K, Jensen EW, Raeder J. Can the cerebral state monitor replace the bispectral index in monitoring hypnotic effect during propofol/remifentanil anaesthesia? Acta Anaesthesiol Scand 2007;51:210-6.
Zanner R, Pilge S, Kochs EF, Kreuzer M, Schneider G. Time delay of electroencephalogram index calculation: Analysis of cerebral state, bispectral, and Narcotrend indices using perioperatively recorded electroencephalographic signals. Br J Anaesth 2009;103:394-9.
Osborne GA, Bacon AK, Runciman WB, Helps SC. Crisis management during anaesthesia: Awareness and anaesthesia. Qual Saf Health Care 2005;14:e16.
Somchai A. Monitoring for depth of anaesthesia: A review. J Biomed Graph Comput 2012;2:120-7.
Rani DD, Harsoor SS. Depth of general anaesthesia monitors. Ind Jr Anaesth. 2012;56:437-441.
Hahnenkamp K, Herroeder S, Hollmann MW. Regional anaesthesia, local anaesthetics and the surgical stress response. Best Pract Res Clin Anaesthesiol 2004;18:509-27.
Luginbühl M, Schumacher PM, Vuilleumier P, Vereecke H, Heyse B, Bouillon TW, et al.
Noxious stimulation response index: A novel anesthetic state index based on hypnotic-opioid interaction. Anesthesiology 2010;112:872-80.
Practice advisory for intraoperative awareness and brain function monitoring: A report by the American Society of Anesthesiologists Task Force on Intraoperative Awareness. Anesthesiology 2006; 104:847-64.
Gordon AC, Russell JA. Goal directed therapy: How long can we wait? Crit Care 2005;9:647-8.
Sandham JD, Hull RD, Brant RF, Knox L, Pineo GF, Doig CJ, et al.
A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med 2003; 348:5-14.
McKendry M, McGloin H, Saberi D, Caudwell L, Brady AR, Singer M. Randomised controlled trial assessing the impact of a nurse delivered, flow monitored protocol for optimisation of circulatory status after cardiac surgery. BMJ 2004;329:258.
Aya HD, Cecconi M, Hamilton M, Rhodes A. Goal-directed therapy in cardiac surgery: A systematic review and meta-analysis. Br J Anaesth 2013;110:510-7.
Challand C, Struthers R, Sneyd JR, Erasmus PD, Mellor N, Hosie KB, et al.
Randomized controlled trial of intraoperative goal-directed fluid therapy in aerobically fit and unfit patients having major colorectal surgery. Br J Anaesth 2012;108:53-62.
Brandstrup B, Svendsen PE, Rasmussen M, Belhage B, Rodt SÅ, Hansen B, et al.
Which goal for fluid therapy during colorectal surgery is followed by the best outcome: Near-maximal stroke volume or zero fluid balance? Br J Anaesth 2012;109:191-9.
Price JD, Sear JW, Venn RM. Perioperative fluid volume optimization following proximal femoral fracture. Cochrane Database Syst Rev 2004;1:CD003004.
Hood JA, Wilson RJ. Pleth variability index to predict fluid responsiveness in colorectal surgery. Anesth Analg 2011;113: 1058-63.
Abbas SM, Hill AG. Systematic review of the literature for the use of oesophageal Doppler monitor for fluid replacement in major abdominal surgery. Anaesthesia 2008;63:44-51.
National Institute for Health and Clinical Excellence. Cardio Q-ODM oesophageal Doppler monitor. Medical Technology Guide 3. CardioQ-ODM Oesophageal Doppler Monitor; March, 2011. Available from: http://www.nice.org.uk/guidance/MTG3
Singer M. Oesophageal Doppler monitoring: Should it be routine for high-risk surgical patients? Curr Opin Anaesthesiol 2011;24: 171-6.
Erlanger J, Hooker DR. An experimental study of blood pressure and of pulse-pressure in man. Johns Hopkins Hosp Rep 1904;12: 145-378.
Jansen JR, Schreuder JJ, Mulier JP, Smith NT, Settels JJ, Wesseling KH. A comparison of cardiac output derived from the arterial pressure wave against thermodilution in cardiac surgery patients. Br J Anaesth 2001;87:212-22.
Patrick S, Stephan L, Lothar S. Peri-operative haemodynamic monitoring with Transesophageal Doppler Technology. Anaesth and Analg 2009;2:340-353.
Murtha W, Guenther C. Dynamic left ventricular outflow tract obstruction complicating bilateral lung transplantation. Anesth Analg 2002;94:558-9.
Kihara C, Murata K, Wada Y, Hadano Y, Ohyama R, Okuda S, et al.
Impact of intraoperative transesophageal echocardiography in cardiac and thoracic aortic surgery: Experience in 1011 cases. J Cardiol 2009;54:282-8.
Kallmeyer IJ, Collard CD, Fox JA, Body SC, Shernan SK. The safety of intraoperative transesophageal echocardiography: A case series of 7200 cardiac surgical patients. Anesth Analg 2001; 92:1126-30.
Slama MA, Novara A, Van de Putte P, Diebold B, Safavian A, Safar M, et al.
Diagnostic and therapeutic implications of transesophageal echocardiography in medical ICU patients with unexplained shock, hypoxemia, or suspected endocarditis. Intensive Care Med 1996; 22:916-22.
Lennon MJ, Gibbs NM, Weightman WM, Leber J, Ee HC, Yusoff IF. Transesophageal echocardiography-related gastrointestinal complications in cardiac surgical patients. J Cardiothorac Vasc Anesth 2005;19:141-5.
Mathur SK, Singh P. Transoesophageal echocardiography related complications. Indian J Anaesth 2009;53:567-74.
Aronson S, Thys DM. Training and certification in perioperative transesophageal echocardiography: A historical perspective. Anesth Analg 2001;93:1422-7.
Hogue CW Jr, Lappas GD, Creswell LL, Ferguson TB Jr, Sample M, Pugh D, et al.
Swallowing dysfunction after cardiac operations. Associated adverse outcomes and risk factors including intraoperative transesophageal echocardiography. J Thorac Cardiovasc Surg 1995;110:517-22.
Rousou JA, Tighe DA, Garb JL, Krasner H, Engelman RM, Flack JE 3 rd
, et al.
Risk of dysphagia after transesophageal echocardiography during cardiac operations. Ann Thorac Surg 2000;69:486-9.
Owall A, Ståhl L, Settergren G. Incidence of sore throat and patient complaints after intraoperative transesophageal echocardiography during cardiac surgery. J Cardiothorac Vasc Anesth 1992;6:15-6.
Stevenson JG. Incidence of complications in pediatric transesophageal echocardiography: Experience in 1650 cases. J Am Soc Echocardiogr 1999;12:527-32.
McNeer RR, Bohórquez J, Ozdamar O, Varon AJ, Barach P. A new paradigm for the design of audible alarms that convey urgency information. J Clin Monit Comput 2007;21:353-63.
Oberli C, Urzua J, Saez C, Guarini M, Ciprianio A, Garayar B, et al.
An expert system for monitor alarm integration. J Clin Monit Comput 1999;15:29-35.
Eberhard K, Gerhard S. Algesimetry: Concept for intelligent anaesthesia monitors. Internet J Pain 2001;2:1.
Bonhomme V, Uutela K, Hans G, Maquoi I, Born JD, Brichant JF, et al.
Comparison of the surgical Pleth Index™ with haemodynamic variables to assess nociception-anti-nociception balance during general anaesthesia. Br J Anaesth 2011;106:101-11.
Ledowski T, Bromilow J, Paech HJ, Horm H, Hacking R, Schug SA. Monitoring of skin conductance to assess postoperative pain intensity. Br J Anaesth 2006;97:862-65.
Ledowski T, Bromilow J, Paech HJ, Horm H, Hacking R, Schug SA. Skin conductance as a measure of postoperative pain by monitoring skin conductance: Result of a prospective study. Anaesthesia 2007; 62:983-93.
Ledowski T, Ang B, Schmarbeck T, Rhodes J. Monitoring of sympathetic tone to assess postoperative pain: Skin conductance vs surgical stress index. Anaesthesia 2009;64:727-31.
Storm H. What should the researchers do when they are not able to reproduce their own findings? Anaesthesia 2009; 64:781-2.
Bergmann I, Göhner A, Crozier TA, Hesjedal B, Wiese CH, Popov AF, et al.
Surgical pleth index-guided remifentanil administration reduces remifentanil and propofol consumption and shortens recovery times in outpatient anaesthesia. Br J Anaesth 2013; 110: 622-8.
[Table 1], [Table 2], [Table 3]
|This article has been cited by|
||Perioperative Quality Initiative consensus statement on intraoperative blood pressure, risk and outcomes for elective surgery
| ||Daniel I. Sessler,Joshua A. Bloomstone,Solomon Aronson,Colin Berry,Tong J. Gan,John A. Kellum,James Plumb,Monty G. Mythen,Michael P.W. Grocott,Mark R. Edwards,Timothy E. Miller,Timothy E. Miller,Monty G. Mythen,Michael PW. Grocott,Mark R. Edwards,Gareth L. Ackland,Charles S. Brudney,Maurizio Cecconi,Can Ince,Michael G. Irwin,Jonathan Lacey,Michael R. Pinsky,Robert Sanders,Finton Hughes,Angela Bader,Annemarie Thompson,Andreas Hoeft,David Williams,Andrew D. Shaw,Daniel I. Sessler,Sol Aronson,Colin Berry,Tong J. Gan,John Kellum,James Plumb,Joshua Bloomstone,Matthew D. McEvoy,Julie K.M. Thacker,Ruchir Gupta,Elena Koepke,Aarne Feldheiser,Denny Levett,Frederic Michard,Mark Hamilton |
| ||British Journal of Anaesthesia. 2019; |
|[Pubmed] | [DOI]|
||Joint consensus on abdominal robotic surgery and anesthesia from a task force of the SIAARTI and SIC
| ||Antonio Corcione,Pierluigi Angelini,Lapo Bencini,Elisabetta Bertellini,Felice Borghi,Claudio Buccelli,Giuseppe Coletta,Clelia Esposito,Vincenzo Graziano,Fabio Guarracino,Domenico Marchi,Pasquale Misitano,Anna M. Mori,Mariano Paternoster,Vincenzo Pennestŕ,Vittorio Perrone,Luigi Pugliese,Stefano Romagnoli,Luigia Scudeller,Francesco Corcione |
| ||Minerva Anestesiologica. 2018; 84(10) |
|[Pubmed] | [DOI]|
||Cost-effectiveness of anesthesia maintained with sevoflurane or propofol with and without additional monitoring: a prospective, randomized controlled trial
| ||Timea Bocskai,Csaba Loibl,Zoltan Vamos,Gabor Woth,Tihamer Molnar,Lajos Bogar,Laszlo Lujber |
| ||BMC Anesthesiology. 2018; 18(1) |
|[Pubmed] | [DOI]|
||Design of spiking neural networks for blood pressure prediction during general anesthesia: considerations for optimizing results
| ||Go Hamano,Andrew Lowe,David Cumin |
| ||Evolving Systems. 2017; |
|[Pubmed] | [DOI]|
||Use of Transesophageal Echocardiography to Improve the Safety of Transvenous Lead Extraction
| ||Brett A. Oestreich,Bryan Ahlgren,Tamas Seres,Matthew M. Zipse,Christine Tompkins,Paul D. Varosy,Ryan G. Aleong |
| ||JACC: Clinical Electrophysiology. 2015; 1(5): 442 |
|[Pubmed] | [DOI]|
||Pulmonary Artery Catheter Use During Cardiac Surgery in the United States, 2010 to 2014
| ||Ethan Y. Brovman,Rodney A. Gabriel,Richard P. Dutton,Richard D. Urman |
| ||Journal of Cardiothoracic and Vascular Anesthesia. 2015; |
|[Pubmed] | [DOI]|